Neuphoria (NEUP) - Yalpi foyda koeffitsiyenti

NEUP (Neuphoria Therapeutics Inc.) - kompaniyaning tovar belgisi

Yuqori tartibga solish to'siqlari va operatsion yo'qotishlar Neuphoria Therapeutics Inc. (NEUP) kapitaliga sezilarli bosim o'tkazmoqda. Choraklik yalpi foyda marjalari joriy asosiy daromadlilik tendentsiyalarini aks ettirmoqda va ushbu ko'rsatkich 43.60 darajasida turibdi. Sog'liqni saqlash gigantlari bilan strategik ittifoqlar molekulalarni kashf qilish xarajatlarini optimallashtirishga yordam beradi, kimyogarlar va tadqiqotchilar xodimlari o'rtasidagi sinergiya esa xavotir buzilishlari uchun davolash vositalarining yuqori sifatli ishlab chiqilishini ta'minlaydi.

NEUP (bionomics.com.au) Yalpi marja tarixi 25.12.2024dan 20.11.2026gacha

Neuphoria Therapeutics (NEUP) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor kapitallashuvi ko'rsatkichlari:
- pul mablag'lari va pul oqimlari statistikasi:
Kompaniyaning asosiy tahlili:Neuphoria Therapeutics Inc. NEUP
bionomics.com.au tomonidan chiqariladigan mahsulotlar

Yalpi marja bevosita xarajatlardan keyin qolgan tushum qismini aniqlash orqali ishlab chiqarish samaradorligini o'lchaydi, bu esa investorlarga biznes modelining fundamental barqarorligini baholash imkonini beradi. Tushumning yalpi foyda foizini tahlil qilish orqali, Neuphoria Therapeutics Inc. (NEUP) kompaniyasining noyob molekulalarga tegishli intellektual mulki, nevrologik dori vositalari uchun FDA ning qat'iy tartibga soluvchi xavfsizlik talablari mavjudligiga qaramay, marjalarni raqobatdan qanday himoya qilishini ko'rish mumkin.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|ACIU: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VYGR (Voyager Corp)|Yalpi foyda bo'yicha rentabellik Neumora NMRA|Yalpi rentabellik Scilex Holding Company, Inc. SCLX|Sotuvning yalpi marjinal rentabelligi Tevogen Bio Inc.|ACOG - Yalpi rentabellik|Sotuvning yalpi marjinal rentabelligi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Yalpi foyda bo'yicha rentabellik|Cassava Sciences Inc (SAVA) - Yalpi marja|Yalpi foyda bo'yicha rentabellik ASRT|Yalpi marja coyatherapeutics.com|Yalpi marja VTGN|Ovid Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Yalpi foyda bo'yicha rentabellik|ATHE - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi clene.com CLNN|PEPG: Yalpi marja|Sotuvning yalpi rentabelligi JUNS|RLMD (Relmada Corp) - Yalpi marja|Annovis Bio Inc (ANVS) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Yalpi foyda normasi|Yalpi rentabellik Klotho Neurosciences KLTO|NRSN: Sotuvning yalpi rentabelligi|RVPH: Yalpi foyda bo'yicha rentabellik|MTVA: Yalpi rentabellik|NRXS (NeurAxis Inc) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Helius Medical Technologies, Inc.|Yalpi rentabellik Passage Bio Inc.|Yalpi rentabellik NERV|Yalpi marja ATHA|ADXN (Addex Therapeutics Ltd) - Yalpi foyda normasi|Yalpi rentabellik alzamend.com ALZN|Yalpi foyda bo'yicha sotuv rentabelligi Cyclerion Therapeutics (CYCN)|Protagenic - Yalpi marja|Yalpi foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Yalpi marja|Avenue Therapeutics Inc. (ATXI) - Yalpi marja|BCLI (BrainStorm Cell Therapeutics Inc.) - Yalpi marja|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)